CAG
EDIT icon

Crestwood Advisors Group’s Editas Medicine EDIT Stock Holding History

Crestwood Advisors Group’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-12,960
Closed -$107K – 368
2023
Q2 		$107K Hold
12,960
– – ﹤0.01% 248
2023
Q1 		$94K Sell
12,960
-2,750
-18% -$24.4K ﹤0.01% 252
2022
Q4 		$139K Hold
15,710
– – ﹤0.01% 254
2022
Q3 		$192K Sell
15,710
-2,000
-11% -$31.2K 0.01% 251
2022
Q2 		$210K Sell
17,710
-450
-2% -$6.03K 0.01% 245
2022
Q1 		$345K Sell
18,160
-1,150
-6% -$21.4K 0.01% 231
2021
Q4 		$513K Sell
19,310
-1,170
-6% -$40.3K 0.01% 203
2021
Q3 		$841K Sell
20,480
-5,180
-20% -$284K 0.02% 161
2021
Q2 		$1.45M Sell
25,660
-2,500
-9% -$92.3K 0.04% 135
2021
Q1 		$1.18M Sell
28,160
-300
-1% -$17.1K 0.04% 141
2020
Q4 		$2M Sell
28,460
-1,790
-6% -$73.5K 0.07% 118
2020
Q3 		$849K Sell
30,250
-2,000
-6% -$65.1K 0.03% 135
2020
Q2 		$954K Hold
32,250
– – 0.04% 123
2020
Q1 		$640K Sell
32,250
-525
-2% -$13.2K 0.03% 139
2019
Q4 		$970K Sell
32,775
-19,425
-37% -$485K 0.04% 138
2019
Q3 		$1.19M Sell
52,200
-5,800
-10% -$144K 0.05% 121
2019
Q2 		$1.44M Hold
58,000
– – 0.07% 118
2019
Q1 		$1.42M Sell
58,000
-27,281
-32% -$617K 0.1% 69
2018
Q4 		$1.94M Hold
85,281
– – 0.15% 63
2018
Q3 		$2.71M Hold
85,281
– – 0.19% 62
2018
Q2 		$2.5M Sell
85,281
-200
-0.2% -$7.08K 0.18% 63
2018
Q1 		$2.83M Hold
85,481
– – 0.22% 61
2017
Q4 		$2.63M Sell
85,481
-4,656
-5% -$117K 0.21% 62
2017
Q3 		$2.16M Sell
90,137
-49,211
-35% -$937K 0.19% 61
2017
Q2 		$2.39M Buy
139,348
+23,411
+20% +$422K 0.2% 62
2017
Q1 		$2.37M Buy
+115,937
New +$2.4M 0.21% 61

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Crestwood Advisors Group's EDIT Position: Q3 2023 in Review

Crestwood Advisors Group sold out of Editas Medicine (EDIT) in Q3 2023, closing a stake of 12,960 shares — an estimated $107K sold.

Crestwood Advisors Group first reported a position in EDIT in Q1 2017 and held it in 26 quarters. The position peaked at $2.83M in Q1 2018. 220 funds tracked by Wall St. Rank hold EDIT as of Q3 2023.

  • Crestwood Advisors Group reported no remaining Editas Medicine position as of Q3 2023 after selling out during the quarter.
  • Crestwood Advisors Group sold 12,960 Editas Medicine shares in Q3 2023, an estimated $107K.
  • Crestwood Advisors Group first reported a position in Editas Medicine in Q1 2017 and held it in 26 quarters.
  • Crestwood Advisors Group's Editas Medicine position peaked at $2.83M in Q1 2018.
  • 220 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2023.

Based on Crestwood Advisors Group's 13F filing for Q3 2023, filed 15 Nov 2023.